Skip to content

Effect of Laghumanjisthadi Kwath in patient with Sheetapitta to reduce Itching and Swelling

A Randomized controlled clinical trial to Evaluate the Efficacy of Laghumanjisthadi Kwath in the Management of Sheetapitta WSR Urticaria. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105194
Enrollment
90
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L501- Idiopathic urticaria

Interventions

None listed

Sponsors

Dr Rutuja Prashant Yelmote
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient in the age of 20 to 60 regardless of gender,religion,profession 2. This study involve patient with history of sheetapitta of at least 1yr and sheetapitta granthokta Lakshmana- varatidashta sansthanavata shotha Kandu Toda Vidaha Jwara 3.chronic urticaria with or without complications for ex. Angioedema 4.informed consent

Exclusion criteria

Exclusion criteria: a) Individuals having k/c/o 1) renal failure. 2) Diabetes mellitus, 3) Systemic lupus Erythematous 4) Rheumatic diseases. 5) Any kind of cancerous illness, leukaemia, metastatic cancer,. b) The patient is receiving treatment for the same issue from another pathy. c) k/c/o Drug-related hypersensitivity responses. d) k/c/o acute urticaria. e) k/c/o Auto-immune urticaria and other auto-immune diseases. f) Pregnant and lactating women g) k/c/o Other skin diseases.

Design outcomes

Primary

MeasureTime frame
Reduction in sign and symptoms of vartidashta sansathanavata shotha,kandu,toda,vidaha,jwaraTimepoint: 1. Total duration of treatment-21 days 2.Assessment on 1st,7th,14th,21st days 3.post treatment follow up-28th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Nilesh Dere

SST Ayurved college Sangamner

Dr.Nilesh.Dere@gmail.com9271292389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026